[Scoundreller]

Correct.

Even American generic manufacturers get a large percentage of their APIs from India. Surprise surprise, weak patent laws mean you get pretty good at making complex things.

The bulk mass-produced excipients/binders/“fillers” often come from China, since that’s what they’re good at.

Pressing tablets and packaging them is fairly commoditized work. The extra cost of doing it in the USA won’t make a perceptible difference to the end-user.

QC is easier when you’re working with verified pure ingredients.

I’m much more worried about food made with imported ingredients than drugs made with imported ingredients.

When a 500k tablet per hour rotary press can be tended to by a person or two and do its thing, labour costs aren’t very relevant.